Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 10,312 | 5,301 | N/A |
| Other current assets | 0 | 71 | 73 | 0 |
| TOTAL | $N/A | $10,383 | $5,374 | $N/A |
| Non-Current Assets | ||||
| PPE Net | N/A | 1,882 | 1,924 | N/A |
| Other Non-Current Assets | 0 | 233 | 130 | 0 |
| TOTAL | $N/A | $2,115 | $2,054 | $N/A |
| Total Assets | $N/A | $12,498 | $7,428 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 342 | 142 | 0 |
| Accrued Expenses | N/A | 471 | 344 | N/A |
| Other current liabilities | N/A | 667 | 0 | N/A |
| TOTAL | $N/A | $1,808 | $745 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $481 | $282 | $N/A |
| Total Liabilities | $N/A | $2,289 | $1,027 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | N/A | 2 | 2 | N/A |
| Retained earnings | N/A | -9,754 | -5,711 | N/A |
| Other shareholders' equity | 0 | 19,913 | 12,064 | 0 |
| TOTAL | $N/A | $10,209 | $6,402 | $N/A |
| Total Liabilities And Equity | $0 | $12,498 | $7,428 | $0 |